DOC.REF
Clinical127 LOINC codes in this class
100382-1FDA package insert REMS addressed riskC34066-1FDA package insert Boxed warning sectionC34067-9FDA package insert Indications and usage sectionC34068-7FDA package insert Dosage and administration sectionC34069-5FDA package insert How supplied sectionC34070-3FDA package insert Contraindications sectionC34071-1FDA package insert Warnings sectionC34072-9FDA package insert General precautions sectionC34073-7FDA package insert Drug interactions sectionC34074-5FDA package insert Drug/laboratory test interactions sectionC34075-2FDA package insert Laboratory tests sectionC34076-0FDA package insert Information for patients sectionC34077-8FDA package insert Teratogenic effects sectionC34078-6FDA package insert Nonteratogenic effects sectionC34079-4FDA package insert Labor and delivery sectionC34080-2FDA package insert Nursing mothers sectionC34081-0FDA package insert Pediatric use sectionC34082-8FDA package insert Geriatric use sectionC34083-6FDA package insert Carcinogenesis and mutagenesis and impairment of fertility sectionC34084-4FDA package insert Adverse reactions sectionC34085-1FDA package insert Controlled substance sectionC34086-9FDA package insert Abuse sectionC34087-7FDA package insert Dependence sectionC34088-5FDA package insert Overdosage sectionC34089-3FDA package insert Description sectionC34090-1FDA package insert Clinical pharmacology sectionC34091-9FDA package insert Animal pharmacology/toxicology sectionC34092-7FDA package insert Clinical studies sectionC34093-5FDA package insert References sectionC38056-8FDA package insert Structured product laballing supplemental patient materialC42227-9FDA package insert Drug abuse and dependence sectionC42228-7FDA package insert Pregnancy sectionC42229-5FDA package insert Structured patient labelling unclassified sectionC42230-3FDA package insert Structured product laballing patient package insert sectionC42231-1FDA package insert Structured product labelling medguide sectionC42232-9FDA package insert Precautions sectionC43678-2FDA package insert Dosage forms and strengths sectionC43679-0FDA package insert Mechanism of action sectionC43680-8FDA package insert Nonclinical toxicology sectionC43681-6FDA package insert Pharmacodynamics sectionC43682-4FDA package insert Pharmacokinetics sectionC43683-2FDA package insert Recent major changes sectionC43684-0FDA package insert Use in specific populations sectionC43685-7FDA package insert Warnings and precautions sectionC44425-7FDA package insert Storage and handling sectionC48779-3FDA package insert Structured product labelling indexing data elements sectionC48780-1FDA package insert Structured product labelling listing data elements sectionC49489-8FDA package insert Microbiology sectionC51941-3FDA product label Back panel of packageC51942-1FDA product label Side panel of package RightC51943-9FDA product label Side panel of package LeftC51944-7FDA product label Side panel of packageC51945-4FDA product label Principal display panel of packageC51946-2FDA product label Top panel of packageC51947-0FDA product label Bottom panel of packageC51948-8FDA product label Flap panel of packageC54433-8FDA package insert User safety warnings sectionC59845-8FDA package insert Instructions for use sectionC60555-0FDA package insert AccessoriesC60556-8FDA package insert Assembly or installation instructionsC60557-6FDA package insert Calibration instructionsC60558-4FDA package insert Cleaning, disinfecting, and sterilization instructionsC60559-2FDA package insert ComponentsC60560-0FDA package insert Intended use of the deviceC60561-8FDA package insert Other safety informationC60573-3Report template sourceC60683-0FDA product label Plasma derivativeC60684-8FDA product label Cellular therapyC60685-5FDA package insert Indexing - pharmacologic classC64123-3FDA package insert Indexing - adverse reactionC64124-1FDA package insert Indexing - substanceC66105-8FDA package insert Lot distribution dataC66106-6FDA package insert Pharmacogenomics sectionC69718-5FDA product label Statement of identity sectionC69719-3FDA product label Health claim sectionC69758-1FDA package insert Diagram of deviceC69759-9FDA package insert RisksC69760-7FDA package insert Compatible accessoriesC69761-5FDA package insert AlarmsC69762-3FDA package insert TroubleshootingC69763-1FDA package insert Disposal and waste handlingC71446-9FDA package insert Indexing - billing unitC71681-1FDA package insert PMI - Common side effects sectionC71682-9FDA package insert PMI - Get emergency medical help sectionC71683-7FDA package insert PMI - Stop taking and call your doctor sectionC71684-5FDA package insert PMI - Directions for use sectionC71685-2FDA package insert PMI - Tell your doctor before taking sectionC71686-0FDA package insert PMI - Do not take sectionC71687-8FDA package insert PMI - Important information sectionC71688-6FDA package insert PMI - Uses sectionC71743-9FDA product label Generic drug facility identification submissionC71744-7FDA package insert Health care provider letterC72090-4FDA product label Identification of CBER-regulated generic drug facilityC73815-3FDA package insert Indexing - product conceptC77288-9FDA package insert Indexing - warning letter alertC77289-7FDA package insert Identification of suspect product and notificationC77290-5FDA package insert LactationC77291-3FDA package insert Females and males reproductive potentialC77292-1FDA package insert eFacilityC77573-4FDA product label Withdrawal of wholesale drug distributors and third-party logistics facility reportC82336-9FDA package insert REMS headerC82344-3FDA package insert REMS communication planC82345-0FDA package insert REMS elements to assure safe useC82346-8FDA package insert REMS materialC82347-6FDA package insert REMS summaryC82348-4FDA package insert REMS elementsC82349-2FDA package insert REMS goalsC82350-0FDA package insert REMS implementation systemC82351-8FDA package insert Risk evaluation and mitigation strategiesC82352-6FDA package insert REMS timetable for submission assessmentsC82353-4FDA package insert Indexing - risk evaluation and mitigation strategiesC82598-4FDA package insert REMS medication guideC85273-1FDA package insert REMS conversion to shared systemC85274-9FDA package insert REMS releaseC87523-7FDA package insert REMS administrative informationC87524-5FDA package insert REMS requirementsC87525-2FDA package insert REMS participant requirementsC87526-0FDA package insert REMS applicant requirementsC88436-1FDA package insert Patient counseling informationC88437-9FDA package insert How supplied and storage and handling sectionC88828-9FDA package insert Renal Impairment subsectionC88829-7FDA package insert Hepatic Impairment subsectionC88830-5FDA package insert ImmunogenicityC89600-1FDA product label FDA-initiated compliance action drug registration and listing inactivationC90374-0FDA package insert Clinical trials experience sectionC90375-7FDA package insert Postmarketing experience sectionC99282-6FDA product label FDA-initiated compliance action drug registration and listing inactivation - animal drugC